Cannabis and Mental Health: Evidence, Risks, and Realities is organized by Hatherleigh Medical Education.
Lessons: 3
Instructional Level: Intermediate
Continuing Medical Education (CME) Course Curriculum
Part I: History and Epidemiology
After completing this educational activity, participants will be able to (1) summarize the history, trends, and prevalence of marijuana use and marijuana use disorder (MUD) in the United States; (2) describe epidemiological trends that influence prevalence rates; and (3) delineate attitudes toward legalization of the medicinal and recreational use of marijuana and their impact on prevalence.
Part II: Neurobiology and Health Impact of Marijuana
After completing this educational activity, participants will be able to (1) demonstrate under-standing of the endocannabinoid system, and its functional role in both central and peripheral systems; (2) differentiate the function of Cannabinoid 1 (CB-1) from Cannabinoid 2 (CB-2) receptors; and (3) describe risk factors and psychopathology associated with ?-9-tetrahydrocannabinol (THC) consumption.
Part III: Risk Factors, Diagnosis, and Treatment of Cannabis Use Disorder
After completing this educational activity, participants will be able to: (1) describe the effects of liberalized state marijuana laws on public health and safety; (2) delineate the risk factors, symptoms, and characteristics of cannabis use disorder (CUD) in adolescents and adults, including the prevalence of co-occurring psychiatric disorders; (3) explain the strategies and clinical modalities commonly used for the assessment and diagnosis of CUD; (4) discuss the strategies and clinical modalities of current evidenced-based interventions for CUD—including motivational interviewing, motivational enhancement, and psychoeducational group therapy—in terms of the chronic disease management model of treatment and recovery.